Previous Article | Next Article ![]()
Journal of Clinical Microbiology, September 2001, p. 3135-3139, Vol. 39, No. 9
Institute of Medical Virology, University of
Zurich,1 and Department of Infectious
Diseases, University Children's Hospital,2
Zurich, Switzerland
Received 16 January 2001/Returned for modification 10 May
2001/Accepted 11 July 2001
By using a rapid test for respiratory syncytial virus (RSV)
detection (Abbott TestPack RSV), a number of patients were observed, showing repeatedly positive results over a period of up to 10 weeks. A
prospective study was initiated to compare the rapid test with an
antigen capture enzyme immunoassay (EIA) and a nested reverse
transcriptase PCR (RT-PCR) protocol for detection of RSV serotypes A
and B. Only respiratory samples from children exhibiting the prolonged
presence of RSV (
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.9.3135-3139.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Reliable Detection of Respiratory Syncytial Virus
Infection in Children for Adequate Hospital Infection Control
Management
5 days) as determined by the rapid test were
considered. A total of 134 specimens from 24 children was investigated
by antigen capture EIA and nested RT-PCR. Using RT-PCR as the reference
method, we determined the RSV rapid test to have a specificity of 63%
and a sensitivity of 66% and the antigen capture EIA to have a
specificity of 96% and a sensitivity of 69% for acute-phase samples
and the homologous virus serotype A. In 7 (29%) of 24 patients, the
positive results of the RSV rapid test could not be confirmed by either
nested RT-PCR or antigen capture EIA. In these seven patients a variety
of other respiratory viruses were detected. For general screening the
RSV rapid test was found to be a reasonable tool to get quick results.
However, its lack of specificity in some patients requires confirmation by additional tests to rule out false-positive results and/or detection
of other respiratory viruses.
*
Corresponding author. Mailing address: Institute of
Medical Virology, University of Zurich, Diagnostic Department,
Gloriastrasse 30, CH-8028 Zurich, Switzerland. Phone: 41 1 634 26 59. Fax: 41 1 634 49 06. E-mail: bossart{at}immv.unizh.ch.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|